Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

552
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
552
Relative Risk01:12

Relative Risk

2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

545
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
545
Odds Ratio01:09

Odds Ratio

2.3K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
2.3K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

340
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
340
Actuarial Approach01:20

Actuarial Approach

373
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
373

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-risk pooling for mitigating risk selection incentives in health insurance markets with sophisticated risk equalization: an application based on health survey information.

BMC health services research·2024
Same author

Selection Incentives in the Dutch Basic Health Insurance: To What Extent Does End-of-Life Spending Contribute to Predictable Profits and Losses for Selective Groups?

Medical care research and review : MCRR·2022
Same author

Can risk rating increase the ability of voluntary deductibles to reduce moral hazard?

The Geneva papers on risk and insurance. Issues and practice·2021
Same author

Incorporating self-reported health measures in risk equalization through constrained regression.

The European journal of health economics : HEPAC : health economics in prevention and care·2020
Same author

Examining unpriced risk heterogeneity in the Dutch health insurance market.

The European journal of health economics : HEPAC : health economics in prevention and care·2018
Same author

Can premium differentiation counteract adverse selection in the Dutch supplementary health insurance? A simulation study.

The European journal of health economics : HEPAC : health economics in prevention and care·2017
Same journal

Cost-effectiveness of community versus hospital-based mental healthcare for severe mental illness in South-East Europe: economic evaluation of five randomised trials.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

Coordinating care across hospitals: how integration shapes patient mobility.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

A comparative analysis of managed entry agreements in Europe: trends, reporting practices, and financial outcomes.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

Comparing universal health coverage models: an analysis of policy transmission efficiency in SAARC and ASEAN countries.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

Development and validation of solomon's socioeconomic status index (SESI): a multidimensional household classification tool for South Asia.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

Who pays and Who benefits? A distributional health-economic evaluation of strengthening the UK soft drinks industry levy.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
See all related articles

Related Experiment Video

Updated: Apr 1, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Overpaying morbidity adjusters in risk equalization models.

R C van Kleef1, R C J A van Vliet2, W P M M van de Ven2

  • 1Institute of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands. vankleef@bmg.eur.nl.

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|October 1, 2015
PubMed
Summary
This summary is machine-generated.

Risk equalization in social health insurance often undercompensates for high-risk individuals. Overpaying existing morbidity adjusters can reduce insurer risk selection incentives, especially for pharmacy costs.

Keywords:
Health insuranceOverpayingRisk equalizationRisk selection

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Related Experiment Videos

Last Updated: Apr 1, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Area of Science:

  • Health Economics
  • Social Health Insurance
  • Risk Management

Background:

  • Competitive social health insurance markets utilize risk equalization to manage healthcare expense variations.
  • Existing risk equalization models, even with advanced morbidity adjusters, often undercompensate insurers for high-risk individuals.
  • This undercompensation, coupled with premium regulation, creates incentives for risk selection among consumers and insurers.

Purpose of the Study:

  • To propose a method to reduce risk selection incentives in social health insurance.
  • To address the undercompensation of high-risk individuals by modifying existing risk equalization mechanisms.
  • To explore the potential of 'overpaying' morbidity adjusters within risk equalization models.

Main Methods:

  • The study proposes overpaying morbidity adjusters already incorporated into the risk equalization model.
  • The concept is illustrated by merging morbidity adjuster data, healthcare expenses, and health survey information.
  • Three preconditions for the meaningful application of this 'overpaying' strategy are derived.

Main Results:

  • The proposed method aims to mitigate undercompensation for specific high-risk groups.
  • Merging diverse datasets provides a basis for evaluating the proposed adjustment.
  • The findings suggest that 'overpaying' may be particularly effective for pharmacy-based cost groups.

Conclusions:

  • Overpaying existing morbidity adjusters is a potential strategy to reduce risk selection in social health insurance.
  • The effectiveness of this approach depends on specific preconditions related to data and model application.
  • Pharmacy-based cost groups represent a promising area for the implementation of this 'overpaying' strategy.